Adam Ang
It is now set to take on the international markets three years after its inception.
This is the latest in its string of acquisitions to expand its digital health portfolio.
This marks the Australian company's expansion into Saudi's private health sector after cementing its presence in its public health system.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
Also, Optiscan is working with Mayo Clinic to develop a digital endomicroscopic imaging system for robotic surgery.
Hackers may have entered through one of its third-party vendors.
Sonio will remain an independent company following the acquisition.
It will validate BrainEye's 60-second eye movement test to about 500 participants.
It confidently relies on expert knowledge based on two decades of research with young people.